Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 2,000 shares changing hands.
Resverlogix Trading Down 5.0%
The company has a market capitalization of C$27.21 million, a P/E ratio of -2.38 and a beta of 0.78. The company has a quick ratio of 0.04, a current ratio of 0.13 and a debt-to-equity ratio of -10.95. The firm’s 50-day moving average price is C$0.10 and its 200 day moving average price is C$0.08.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Resverlogix
- What is a Stock Market Index and How Do You Use Them?
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- Pros And Cons Of Monthly Dividend Stocks
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Top Biotech Stocks: Exploring Innovation Opportunities
- AI Demand Is Coming—Is Microchip Technology Ready?
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
